Alexander M. Gold's most recent trade in Mineralys Therapeutics Inc was a trade of 15,000 Stock Option done . Disclosure was reported to the exchange on Nov. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 15,000 | 17,900 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 15,000 | 15,000 | - | 10.2 | 153,000 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 11 Nov 2025 | 12,742 | 0 | - | 46.5 | 592,503 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 10,000 | 34,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.69 per share. | 11 Nov 2025 | 10,000 | 12,742 | - | 12.7 | 126,900 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 11 Nov 2025 | 10,000 | 5,000 | - | 42.4 | 424,298 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 6,933 | 10,967 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 6,933 | 6,933 | - | 10.2 | 70,717 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 11 Nov 2025 | 5,000 | 1,933 | - | 46.5 | 232,500 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 47.08 per share. | 11 Nov 2025 | 5,000 | 0 | - | 47.1 | 235,408 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 2,742 | 8,225 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share. | 11 Nov 2025 | 2,742 | 2,742 | - | 10.2 | 27,968 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Sale of securities on an exchange or to another person at price $ 47.28 per share. | 11 Nov 2025 | 1,933 | 0 | - | 47.3 | 91,386 | Common Stock |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option |